Breast Cancer Clinical Trial

HeartPhone Cancer Survivors Trial 2019

Summary

This is a behavioral study that will examine changes in physical activity and vascular health in response to a digital tool (app) that will appear on participant's lock screen of their Android phone. Participants will be asked to use this app for 3 months and to wear a Fitbit device continuously throughout the study. Participants will be asked to complete questionnaires, participate in fitness testing and measures of cardiovascular health at 3 months and 6 months after baseline assessments. The hypothesis is that exposure to the app will lead to increased physical activity volume and improved microvessel function.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age 18-65 years
Diagnosis of breast cancer, leukemia, or lymphoma <15 yrs
Completed chemotherapy with cardiotoxic anthracycline-based agents 1+ year ago
English-proficiency
Own & use smartphone with Android operating system

Main Study and Ancillary Study Exclusion Criteria:

Currently receiving curative treatment for cancer
90+ min/week moderate (or greater) intensity PA
Any medical contraindications on the Physical Activity Readiness Questionnaire
Require an assistive device for mobility or has any other condition that may limit or prevent participation in moderate-intensity physical activity
Current smoker
Pregnant or planning to become pregnant in the next 6 mos/breastfeeding
Allergy to test substances
Allergy to latex

Ancillary Study:

Taking metformin
Current medications that could conceivably alter the cardiovascular or thermoregulatory control or responses (e.g. beta blockers, calcium channel blockers, angiotensin receptor blockers)

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

3

Study ID:

NCT03953326

Recruitment Status:

Terminated

Sponsor:

Penn State University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

The Pennsylvania State University
University Park Pennsylvania, 16802, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

3

Study ID:

NCT03953326

Recruitment Status:

Terminated

Sponsor:


Penn State University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider